Loading chat...
US HR1079
Resolution
Status
2/25/2026
Primary Sponsor
Josh Gottheimer
Click for details
AI Summary
-
Charcot-Marie-Tooth disease (CMT) affects an estimated 126,000 individuals in the United States and 2.6 million people worldwide, damaging peripheral nerves and muscles
-
Nearly all CMT cases are inherited, and the specific gene causing the disease has not yet been identified
-
Federal funding for CMT research decreased from 2021 to 2022 despite the disease's significant impact
-
Resolution calls for robust research funding through the National Institute of Neurological Disorders and Stroke at NIH
-
Expresses need for continued investment in research for CMT and other rare diseases that currently have no cure
Legislative Description
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Last Action
Referred to the House Committee on Energy and Commerce.
2/25/2026